Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

54 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Resumption of Trastuzumab in Patients With Disease Recurrence After (Neo-) Adjuvant Anti-HER2-therapy in Patients With HER2-positive Breast Cancer.
Hanker LC, FÖrster F, SchrÖder J, Grafe A, Hitschold T, Hesse T, Lattrich CR, Rody A. Hanker LC, et al. Among authors: grafe a. Anticancer Res. 2020 Jul;40(7):3973-3981. doi: 10.21873/anticanres.14390. Anticancer Res. 2020. PMID: 32620640
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Pfisterer J, Shannon CM, Baumann K, Rau J, Harter P, Joly F, Sehouli J, Canzler U, Schmalfeldt B, Dean AP, Hein A, Zeimet AG, Hanker LC, Petit T, Marmé F, El-Balat A, Glasspool R, de Gregorio N, Mahner S, Meniawy TM, Park-Simon TW, Mouret-Reynier MA, Costan C, Meier W, Reinthaller A, Goh JC, L'Haridon T, Baron Hay S, Kommoss S, du Bois A, Kurtz JE; AGO-OVAR 2.21/ENGOT-ov 18 Investigators. Pfisterer J, et al. Lancet Oncol. 2020 May;21(5):699-709. doi: 10.1016/S1470-2045(20)30142-X. Epub 2020 Apr 16. Lancet Oncol. 2020. PMID: 32305099 Clinical Trial.
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer.
von Minckwitz G, Huang CS, Mano MS, Loibl S, Mamounas EP, Untch M, Wolmark N, Rastogi P, Schneeweiss A, Redondo A, Fischer HH, Jacot W, Conlin AK, Arce-Salinas C, Wapnir IL, Jackisch C, DiGiovanna MP, Fasching PA, Crown JP, Wülfing P, Shao Z, Rota Caremoli E, Wu H, Lam LH, Tesarowski D, Smitt M, Douthwaite H, Singel SM, Geyer CE Jr; KATHERINE Investigators. von Minckwitz G, et al. N Engl J Med. 2019 Feb 14;380(7):617-628. doi: 10.1056/NEJMoa1814017. Epub 2018 Dec 5. N Engl J Med. 2019. PMID: 30516102 Clinical Trial.
Topical azithromycin for the prevention of Lyme borreliosis: a randomised, placebo-controlled, phase 3 efficacy trial.
Schwameis M, Kündig T, Huber G, von Bidder L, Meinel L, Weisser R, Aberer E, Härter G, Weinke T, Jelinek T, Fätkenheuer G, Wollina U, Burchard GD, Aschoff R, Nischik R, Sattler G, Popp G, Lotte W, Wiechert D, Eder G, Maus O, Staubach-Renz P, Gräfe A, Geigenberger V, Naudts I, Sebastian M, Reider N, Weber R, Heckmann M, Reisinger EC, Klein G, Wantzen J, Jilma B. Schwameis M, et al. Among authors: grafe a. Lancet Infect Dis. 2017 Mar;17(3):322-329. doi: 10.1016/S1473-3099(16)30529-1. Epub 2016 Dec 20. Lancet Infect Dis. 2017. PMID: 28007428 Clinical Trial.
Perioperative risk factors in patients with a femoral neck fracture - influence of 25-hydroxyvitamin D and C-reactive protein on postoperative medical complications and 1-year mortality.
Fakler JK, Grafe A, Dinger J, Josten C, Aust G. Fakler JK, et al. Among authors: grafe a. BMC Musculoskelet Disord. 2016 Feb 1;17:51. doi: 10.1186/s12891-016-0906-1. BMC Musculoskelet Disord. 2016. PMID: 26833068 Free PMC article.
Histological behaviour of zirconia implants: an experiment in rats.
Mai R, Kunert-Keil C, Grafe A, Gedrange T, Lauer G, Dominiak M, Gredes T. Mai R, et al. Among authors: grafe a. Ann Anat. 2012 Nov;194(6):561-6. doi: 10.1016/j.aanat.2012.09.004. Epub 2012 Oct 13. Ann Anat. 2012. PMID: 23117031
Regulation of miRNA expression during neural cell specification.
Smirnova L, Gräfe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG. Smirnova L, et al. Among authors: grafe a. Eur J Neurosci. 2005 Mar;21(6):1469-77. doi: 10.1111/j.1460-9568.2005.03978.x. Eur J Neurosci. 2005. PMID: 15845075
[Improved scar formation after using a medical surgical zipper for wound closure under tension].
Zutt M, Emmert S, Hänssle H, Gräfe A, Domhof S, Neumann C, Kretschmer L. Zutt M, et al. Among authors: grafe a. Hautarzt. 2003 Apr;54(4):342-7. doi: 10.1007/s00105-002-0460-7. Epub 2003 Mar 4. Hautarzt. 2003. PMID: 12669206 Clinical Trial. German.
54 results
Jump to page